These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22193838)

  • 1. Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.
    Solomon MD; Ullal AJ; Hoang DD; Freeman JV; Heidenreich P; Turakhia MP
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):86-96. PubMed ID: 22193838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke prevention in atrial fibrillation.
    Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin.
    Lee S; Anglade MW; Meng J; Hagstrom K; Kluger J; Coleman CI
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):472-9. PubMed ID: 22740012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
    Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K
    Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation.
    Lee VW; Tsai RB; Chow IH; Yan BP; Kaya MG; Park JW; Lam YY
    BMC Cardiovasc Disord; 2016 Aug; 16(1):167. PubMed ID: 27581874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation.
    Gibson DN; Price MJ; Ahern TS; Teirstein PS
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):131-7. PubMed ID: 22193834
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers for stroke prevention in atrial fibrillation.
    Prasad V; Kaplan RM; Passman RS
    Cerebrovasc Dis; 2012; 33(3):199-208. PubMed ID: 22261539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
    Han J; Cheng J; Mathuria N
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying future research priorities using value of information analyses: left atrial appendage occlusion devices in atrial fibrillation.
    Micieli A; Bennell MC; Pham B; Krahn M; Singh SM; Wijeysundera HC
    J Am Heart Assoc; 2014 Sep; 3(5):e001031. PubMed ID: 25227405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpharmacologic stroke prevention in atrial fibrillation.
    Onalan O; Lashevsky I; Hamad A; Crystal E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.
    Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ
    Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and stroke management: present and future.
    Holmes DR
    Semin Neurol; 2010 Nov; 30(5):528-36. PubMed ID: 21207345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Le D; Morelli R; Badhwar N; Lee RJ
    Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.